WestEnd Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4K | Buy |
16
+1
| +7% | +$87 | ﹤0.01% | 187 |
|
|
2025
Q1 | $1.02K | Buy |
15
+10
| +200% | +$683 | ﹤0.01% | 209 |
|
|
2024
Q4 | $389 | Hold |
5
| – | – | ﹤0.01% | 202 |
|
|
2024
Q3 | $335 | Hold |
5
| – | – | ﹤0.01% | 231 |
|
|
2024
Q2 | $567 | Sell |
5
-1
| -17% | -$113 | ﹤0.01% | 153 |
|
|
2024
Q1 | $832 | Hold |
6
| – | – | ﹤0.01% | 122 |
|
|
2023
Q4 | $745 | Buy |
6
+1
| +20% | +$124 | ﹤0.01% | 127 |
|
|
2023
Q3 | $467 | Buy |
+5
| New | +$467 | ﹤0.01% | 159 |
|
|
2023
Q2 | – | Hold |
0
| – | -$581 | – | 115 |
|
|
2023
Q1 | – | Sell |
-5
| Closed | -$566 | – | 143 |
|
|
2022
Q4 | $566 | Hold |
5
| – | – | ﹤0.01% | 139 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 190 |
|
|
2022
Q2 | $372 | Buy |
+5
| New | +$372 | ﹤0.01% | 153 |
|
|
2022
Q1 | – | Sell |
-4
| Closed | -$536 | – | 149 |
|
|
2021
Q4 | $536 | Buy |
+4
| New | +$536 | ﹤0.01% | 151 |
|
|
2021
Q3 | – | Hold |
0
| – | -$427K | – | 140 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 162 |
|